$HAE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HAEMONETICS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HAEMONETICS CORP. Get notifications about new insider transactions in HAEMONETICS CORP for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 16 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 27 2015 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Sell | S | 31.75 | 250 | 7,937 | 29,848 | 30.1 K to 29.8 K (-0.83 %) |
Oct 27 2015 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 31.75 | 162 | 5,143 | 19,437 | 19.6 K to 19.4 K (-0.83 %) |
Oct 27 2015 | HAE | HAEMONETICS CORP | Burns Brian R | EVP, Global QA/RA | Sell | S | 31.75 | 249 | 7,906 | 16,235 | 16.5 K to 16.2 K (-1.51 %) |
Oct 23 2015 | HAE | HAEMONETICS CORP | Burns Brian R | EVP, Global QA/RA | Option Exercise | A | 31.97 | 17,186 | 549,436 | 17,186 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Burns Brian R | EVP, Global QA/RA | Option Exercise | A | 0.00 | 7,819 | 0 | 7,819 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Burns Brian R | EVP, Global QA/RA | Grant | A | 0.01 | 3,909 | 39 | 15,719 | 11.8 K to 15.7 K (+33.10 %) |
Oct 23 2015 | HAE | HAEMONETICS CORP | Fusco David | EVP, Global Human R ... | Option Exercise | A | 0.00 | 5,473 | 0 | 5,473 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Fusco David | EVP, Global Human R ... | Option Exercise | A | 31.97 | 12,030 | 384,599 | 12,030 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Fusco David | EVP, Global Human R ... | Grant | A | 0.01 | 2,736 | 27 | 5,415 | 2.7 K to 5.4 K (+102.13 %) |
Oct 23 2015 | HAE | HAEMONETICS CORP | Jesse Sandra | EVP and Chief Legal ... | Option Exercise | A | 0.00 | 6,646 | 0 | 6,646 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Jesse Sandra | EVP and Chief Legal ... | Option Exercise | A | 31.97 | 14,608 | 467,018 | 14,608 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Jesse Sandra | EVP and Chief Legal ... | Grant | A | 0.01 | 3,323 | 33 | 17,971 | 14.6 K to 18 K (+22.69 %) |
Oct 23 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Option Exercise | A | 0.00 | 12,511 | 0 | 12,511 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Option Exercise | A | 31.97 | 27,498 | 879,111 | 27,498 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Grant | A | 0.01 | 6,255 | 63 | 44,443 | 38.2 K to 44.4 K (+16.38 %) |
Oct 23 2015 | HAE | HAEMONETICS CORP | Selman Byron | President, Global M ... | Option Exercise | A | 31.97 | 17,186 | 549,436 | 17,186 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Selman Byron | President, Global M ... | Option Exercise | A | 0.00 | 7,819 | 0 | 7,819 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Selman Byron | President, Global M ... | Grant | A | 0.01 | 3,909 | 39 | 10,902 | 7 K to 10.9 K (+55.90 %) |
Oct 23 2015 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Option Exercise | A | 0.00 | 8,210 | 0 | 8,210 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Option Exercise | A | 31.97 | 18,046 | 576,931 | 18,046 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Grant | A | 0.01 | 4,105 | 41 | 29,333 | 25.2 K to 29.3 K (+16.27 %) |
Oct 23 2015 | HAE | HAEMONETICS CORP | Davies Kent J | Chief Operating Off ... | Option Exercise | A | 0.00 | 19,549 | 0 | 45,960 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Davies Kent J | Chief Operating Off ... | Option Exercise | A | 31.97 | 42,967 | 1,373,655 | 42,967 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Davies Kent J | Chief Operating Off ... | Grant | A | 0.01 | 9,774 | 98 | 16,314 | 6.5 K to 16.3 K (+149.45 %) |
Oct 23 2015 | HAE | HAEMONETICS CORP | Ryding Neil 122-62-507 | EVP, Global Manufac ... | Option Exercise | A | 31.97 | 43,310 | 1,384,621 | 43,310 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Ryding Neil 122-62-507 | EVP, Global Manufac ... | Option Exercise | A | 0.00 | 10,250 | 0 | 10,250 | |
Oct 23 2015 | HAE | HAEMONETICS CORP | Ryding Neil 122-62-507 | EVP, Global Manufac ... | Grant | A | 0.01 | 4,222 | 42 | 4,222 | 0 to 4.2 K |
Sep 16 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.69 | 6,569 | 181,863 | 39,414 | |
Sep 16 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 35.15 | 6,569 | 230,900 | 147,040 | 153.6 K to 147 K (-4.28 %) |
Sep 16 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.69 | 6,569 | 181,896 | 153,609 | 147 K to 153.6 K (+4.47 %) |
Sep 02 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.28 | 4,765 | 129,965 | 4,761 | |
Sep 02 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 35.63 | 4,765 | 169,792 | 147,040 | 151.8 K to 147 K (-3.14 %) |
Sep 02 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.28 | 4,765 | 129,965 | 151,805 | 147 K to 151.8 K (+3.24 %) |
Aug 24 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Option Exercise | M | 26.32 | 4,902 | 128,996 | 0 | |
Aug 24 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | S | 38.49 | 4,902 | 188,688 | 38,188 | 43.1 K to 38.2 K (-11.38 %) |
Aug 24 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Buy | M | 26.32 | 4,902 | 128,996 | 43,090 | 38.2 K to 43.1 K (+12.84 %) |
Aug 18 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.69 | 6,569 | 181,863 | 45,983 | |
Aug 18 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 39.28 | 6,569 | 258,019 | 147,040 | 153.6 K to 147 K (-4.28 %) |
Aug 18 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.69 | 6,569 | 181,863 | 153,609 | 147 K to 153.6 K (+4.47 %) |
Aug 11 2015 | HAE | HAEMONETICS CORP | Fusco David | EVP, Global Human R ... | Option Exercise | A | 0.00 | 11,250 | 0 | 11,250 | |
Aug 11 2015 | HAE | HAEMONETICS CORP | Fusco David | EVP, Global Human R ... | Option Exercise | A | 39.19 | 27,404 | 1,073,985 | 27,404 | |
Aug 11 2015 | HAE | HAEMONETICS CORP | Fusco David | EVP, Global Human R ... | Grant | A | 0.00 | 2,679 | 0 | 2,679 | 0 to 2.7 K |
Aug 04 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.28 | 4,765 | 129,965 | 9,526 | |
Aug 04 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 39.91 | 4,765 | 190,189 | 147,040 | 151.8 K to 147 K (-3.14 %) |
Aug 04 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.28 | 4,765 | 129,965 | 151,805 | 147 K to 151.8 K (+3.24 %) |
Jul 27 2015 | HAE | HAEMONETICS CORP | Davies Kent J | President, Global M ... | Sell | S | 39.36 | 279 | 10,981 | 6,540 | 6.8 K to 6.5 K (-4.09 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | Zane Ellen M | Director | Grant | A | 0.00 | 4,337 | 0 | 11,128 | 6.8 K to 11.1 K (+63.86 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Grant | A | 0.00 | 4,337 | 0 | 16,442 | 12.1 K to 16.4 K (+35.83 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Grant | A | 0.00 | 4,337 | 0 | 16,880 | 12.5 K to 16.9 K (+34.58 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.00 | 4,337 | 0 | 16,732 | 12.4 K to 16.7 K (+34.99 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Grant | A | 0.00 | 4,337 | 0 | 21,632 | 17.3 K to 21.6 K (+25.08 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.00 | 4,337 | 0 | 49,525 | 45.2 K to 49.5 K (+9.60 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Grant | A | 0.00 | 4,337 | 0 | 16,670 | 12.3 K to 16.7 K (+35.17 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | Dockendorff Charles J | Director | Grant | A | 0.00 | 4,337 | 0 | 7,153 | 2.8 K to 7.2 K (+154.01 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | Burns Brian R | EVP, Global QA/RA | Grant | A | 0.00 | 5,103 | 0 | 11,810 | 6.7 K to 11.8 K (+76.08 %) |
Jul 21 2015 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Sell | D | 39.15 | 602 | 23,568 | 25,228 | 25.8 K to 25.2 K (-2.33 %) |
Jul 21 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Option Exercise | M | 26.32 | 4,902 | 128,996 | 4,902 | |
Jul 21 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | S | 39.09 | 4,902 | 191,610 | 38,188 | 43.1 K to 38.2 K (-11.38 %) |
Jul 21 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Buy | M | 26.32 | 4,902 | 128,996 | 43,090 | 38.2 K to 43.1 K (+12.84 %) |
Jul 16 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.69 | 6,569 | 181,863 | 52,552 | |
Jul 16 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 39.59 | 6,569 | 260,092 | 147,040 | 153.6 K to 147 K (-4.28 %) |
Jul 16 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.69 | 6,569 | 181,863 | 153,609 | 147 K to 153.6 K (+4.47 %) |
Jul 08 2015 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Option Exercise | M | 27.28 | 30,494 | 831,724 | 0 | |
Jul 08 2015 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Sell | S | 40.19 | 30,494 | 1,225,651 | 34,102 | 64.6 K to 34.1 K (-47.21 %) |
Jul 08 2015 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Buy | M | 27.28 | 30,494 | 831,724 | 64,596 | 34.1 K to 64.6 K (+89.42 %) |
Jul 07 2015 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Sell | S | 41.14 | 2,385 | 98,119 | 25,620 | 28 K to 25.6 K (-8.52 %) |
Jul 06 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.28 | 4,765 | 129,965 | 14,291 | |
Jul 06 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.28 | 4,765 | 196,711 | 147,040 | 151.8 K to 147 K (-3.14 %) |
Jul 06 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.28 | 4,765 | 129,965 | 151,805 | 147 K to 151.8 K (+3.24 %) |
Jun 23 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Option Exercise | M | 26.32 | 4,902 | 128,996 | 9,804 | |
Jun 23 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | S | 42.51 | 4,902 | 208,394 | 38,188 | 43.1 K to 38.2 K (-11.38 %) |
Jun 23 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Buy | M | 26.32 | 4,902 | 128,996 | 43,090 | 38.2 K to 43.1 K (+12.84 %) |
Jun 17 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.69 | 6,569 | 181,863 | 59,121 | |
Jun 17 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 42.51 | 6,569 | 279,221 | 147,040 | 153.6 K to 147 K (-4.28 %) |
Jun 17 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.69 | 6,569 | 181,863 | 153,609 | 147 K to 153.6 K (+4.47 %) |
Jun 11 2015 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | M | 27.50 | 6,000 | 164,970 | 16,348 | |
Jun 11 2015 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 43.00 | 6,000 | 258,000 | 19,104 | 25.1 K to 19.1 K (-23.90 %) |
Jun 11 2015 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | M | 27.50 | 6,000 | 164,970 | 25,104 | 19.1 K to 25.1 K (+31.41 %) |
Jun 02 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.28 | 4,765 | 129,965 | 19,056 | |
Jun 02 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 41.39 | 4,765 | 197,214 | 147,040 | 151.8 K to 147 K (-3.14 %) |
Jun 02 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.28 | 4,765 | 129,965 | 151,805 | 147 K to 151.8 K (+3.24 %) |
May 21 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Option Exercise | M | 26.32 | 4,902 | 128,996 | 14,706 | |
May 21 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | S | 41.65 | 4,902 | 204,172 | 38,188 | 43.1 K to 38.2 K (-11.38 %) |
May 21 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Buy | M | 26.32 | 4,902 | 128,996 | 43,090 | 38.2 K to 43.1 K (+12.84 %) |
May 11 2015 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | M | 26.47 | 4,000 | 105,880 | 0 | |
May 11 2015 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 40.08 | 4,000 | 160,300 | 19,104 | 23.1 K to 19.1 K (-17.31 %) |
May 11 2015 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | M | 26.47 | 4,000 | 105,880 | 23,104 | 19.1 K to 23.1 K (+20.94 %) |
May 04 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.28 | 4,765 | 129,965 | 23,821 | |
May 04 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 40.74 | 4,765 | 194,139 | 147,040 | 151.8 K to 147 K (-3.14 %) |
May 04 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.28 | 4,765 | 129,965 | 151,805 | 147 K to 151.8 K (+3.24 %) |
Apr 22 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Option Exercise | M | 26.32 | 4,902 | 128,996 | 19,608 | |
Apr 22 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | S | 41.55 | 4,902 | 203,676 | 37,833 | 42.7 K to 37.8 K (-11.47 %) |
Apr 22 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Buy | M | 26.32 | 4,902 | 128,996 | 42,735 | 37.8 K to 42.7 K (+12.96 %) |
Apr 14 2015 | HAE | HAEMONETICS CORP | Helsel Dave | EVP, Global Manufac ... | Sell | D | 43.73 | 302 | 13,206 | 13,216 | 13.5 K to 13.2 K (-2.23 %) |
Apr 02 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.28 | 4,765 | 129,965 | 28,586 | |
Apr 02 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 44.51 | 4,765 | 212,076 | 147,040 | 151.8 K to 147 K (-3.14 %) |
Apr 02 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.28 | 4,765 | 129,965 | 151,805 | 147 K to 151.8 K (+3.24 %) |
Mar 31 2015 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | M | 26.47 | 7,000 | 185,290 | 4,000 | |
Mar 31 2015 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 43.46 | 7,000 | 304,253 | 18,503 | 25.5 K to 18.5 K (-27.45 %) |
Mar 31 2015 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | M | 26.47 | 7,000 | 185,290 | 25,503 | 18.5 K to 25.5 K (+37.83 %) |
Mar 24 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Option Exercise | M | 26.32 | 4,902 | 128,996 | 24,510 | |
Mar 24 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | S | 44.26 | 4,902 | 216,983 | 37,591 | 42.5 K to 37.6 K (-11.54 %) |
Mar 24 2015 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Buy | M | 26.32 | 4,902 | 128,996 | 42,493 | 37.6 K to 42.5 K (+13.04 %) |
Mar 12 2015 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | M | 29.23 | 11,328 | 331,117 | 0 | |
Mar 12 2015 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 43.84 | 11,328 | 496,641 | 12,333 | 23.7 K to 12.3 K (-47.88 %) |
Mar 12 2015 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Buy | M | 29.23 | 11,328 | 331,117 | 23,661 | 12.3 K to 23.7 K (+91.85 %) |
Mar 06 2015 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 29.23 | 11,328 | 331,117 | 0 | |
Mar 06 2015 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 44.76 | 7,707 | 344,936 | 45,188 | 52.9 K to 45.2 K (-14.57 %) |
Mar 06 2015 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 29.23 | 11,328 | 331,117 | 52,895 | 41.6 K to 52.9 K (+27.25 %) |
Mar 05 2015 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Option Exercise | M | 29.72 | 11,758 | 349,448 | 0 | |
Mar 05 2015 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Option Exercise | M | 27.24 | 2,500 | 68,100 | 6,080 | |
Mar 05 2015 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 43.80 | 11,758 | 514,982 | 12,105 | 23.9 K to 12.1 K (-49.27 %) |
Mar 05 2015 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Buy | M | 29.72 | 11,758 | 349,448 | 23,863 | 12.1 K to 23.9 K (+97.13 %) |
Mar 05 2015 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 43.80 | 2,500 | 109,496 | 12,105 | 14.6 K to 12.1 K (-17.12 %) |
Mar 05 2015 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Buy | M | 27.24 | 2,500 | 68,100 | 14,605 | 12.1 K to 14.6 K (+20.65 %) |
Mar 03 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.28 | 4,765 | 129,965 | 33,351 | |
Mar 03 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 44.41 | 4,765 | 211,617 | 147,040 | 151.8 K to 147 K (-3.14 %) |
Mar 03 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.28 | 4,765 | 129,965 | 151,805 | 147 K to 151.8 K (+3.24 %) |
Mar 03 2015 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | M | 29.23 | 11,328 | 331,117 | 0 | |
Mar 03 2015 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 44.80 | 11,328 | 507,483 | 12,395 | 23.7 K to 12.4 K (-47.75 %) |
Mar 03 2015 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Buy | M | 29.23 | 11,328 | 331,117 | 23,723 | 12.4 K to 23.7 K (+91.39 %) |
Feb 19 2015 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | M | 29.23 | 11,328 | 331,117 | 0 | |
Feb 19 2015 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 43.45 | 11,328 | 492,161 | 17,295 | 28.6 K to 17.3 K (-39.58 %) |
Feb 19 2015 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Buy | M | 29.23 | 11,328 | 331,117 | 28,623 | 17.3 K to 28.6 K (+65.50 %) |
Feb 03 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.28 | 4,765 | 129,965 | 38,116 | |
Feb 03 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 39.15 | 4,765 | 186,530 | 147,040 | 151.8 K to 147 K (-3.14 %) |
Feb 03 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.28 | 4,765 | 129,965 | 151,805 | 147 K to 151.8 K (+3.24 %) |
Jan 23 2015 | HAE | HAEMONETICS CORP | Burns Brian R | EVP, Global QA/RA | Sell | D | 37.14 | 237 | 8,802 | 6,103 | 6.3 K to 6.1 K (-3.74 %) |
Jan 06 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.28 | 4,765 | 129,965 | 42,881 | |
Jan 06 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 37.20 | 4,765 | 177,252 | 147,040 | 151.8 K to 147 K (-3.14 %) |
Jan 06 2015 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.28 | 4,765 | 129,965 | 151,805 | 147 K to 151.8 K (+3.24 %) |
Dec 03 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.28 | 4,765 | 129,965 | 47,646 | |
Dec 03 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 36.72 | 4,765 | 174,979 | 147,040 | 151.8 K to 147 K (-3.14 %) |
Dec 03 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.28 | 4,765 | 129,965 | 151,805 | 147 K to 151.8 K (+3.24 %) |
Nov 04 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 27.28 | 4,765 | 129,965 | 52,411 | |
Nov 04 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 35.86 | 4,765 | 170,888 | 147,040 | 151.8 K to 147 K (-3.14 %) |
Nov 04 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 27.28 | 4,765 | 129,965 | 151,805 | 147 K to 151.8 K (+3.24 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | Jesse Sandra | EVP and Chief Legal ... | Sell | D | 36.22 | 276 | 9,997 | 14,648 | 14.9 K to 14.6 K (-1.85 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | Jesse Sandra | EVP and Chief Legal ... | Sell | D | 35.92 | 251 | 9,016 | 14,924 | 15.2 K to 14.9 K (-1.65 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Sell | D | 36.22 | 316 | 11,446 | 27,316 | 27.6 K to 27.3 K (-1.14 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | White Jonathan | Chief Science and T ... | Sell | D | 36.22 | 289 | 10,468 | 27,632 | 27.9 K to 27.6 K (-1.04 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | D | 36.22 | 682 | 24,702 | 37,591 | 38.3 K to 37.6 K (-1.78 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & EVP Business ... | Sell | D | 36.22 | 628 | 22,746 | 38,273 | 38.9 K to 38.3 K (-1.61 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | Helsel Dave | EVP, Global Manufac ... | Sell | D | 35.92 | 251 | 9,016 | 13,123 | 13.4 K to 13.1 K (-1.88 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | D | 36.22 | 186 | 6,737 | 18,503 | 18.7 K to 18.5 K (-1.00 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | D | 36.22 | 210 | 7,606 | 18,689 | 18.9 K to 18.7 K (-1.11 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | D | 35.92 | 144 | 5,172 | 18,899 | 19 K to 18.9 K (-0.76 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 36.22 | 3,215 | 116,447 | 147,040 | 150.3 K to 147 K (-2.14 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 36.22 | 2,794 | 101,199 | 150,255 | 153 K to 150.3 K (-1.83 %) |
Oct 29 2014 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 35.92 | 2,188 | 78,593 | 153,049 | 155.2 K to 153 K (-1.41 %) |